KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Emergent BioSolutions (EBS) Receivables - Other (2017 - 2026)

Emergent BioSolutions has reported Receivables - Other over the past 10 years, most recently at $18.3 million for Q1 2026.

  • For Q1 2026, Receivables - Other fell 40.78% year-over-year to $18.3 million; the TTM value through Mar 2026 reached $18.3 million, down 40.78%, while the annual FY2025 figure was $18.2 million, 7.14% down from the prior year.
  • Receivables - Other for Q1 2026 was $18.3 million at Emergent BioSolutions, up from $18.2 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $82.5 million in Q2 2024 and troughed at $18.2 million in Q4 2025.
  • A 5-year average of $43.4 million and a median of $49.8 million in 2023 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: soared 59.27% in 2024 and later tumbled 72.24% in 2025.
  • Year by year, Receivables - Other stood at $57.2 million in 2022, then fell by 10.14% to $51.4 million in 2023, then plummeted by 61.87% to $19.6 million in 2024, then dropped by 7.14% to $18.2 million in 2025, then rose by 0.55% to $18.3 million in 2026.
  • Business Quant data shows Receivables - Other for EBS at $18.3 million in Q1 2026, $18.2 million in Q4 2025, and $19.3 million in Q3 2025.